Tarsus Pharmaceuticals, Inc. — SC 13G Filings
17 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by Tarsus Pharmaceuticals, Inc. (TARS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Tarsus Pharmaceuticals, Inc. has filed 17 SC 13G documents with the SEC since 2020. To view all SEC filings by Tarsus Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
3/A
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | TARS09302024 13G | 0000053417-24-000089 | Nov 12, 2024 | — |
| SC 13G | — | 0001086364-24-004382 | Jan 26, 2024 | — |
| SC 13G | SC 13G | 0001104659-24-005611 | Jan 22, 2024 | — |
| SC 13G | COWEN FINANCIAL PRODUCTS LLC | 0001085146-23-002078 | May 5, 2023 | — |
| SC 13G | — | 0001306550-23-008509 | Feb 9, 2023 | — |
| SC 13G | — | 0001306550-23-008392 | Feb 8, 2023 | — |
| SC 13G | SC 13G | 0001193125-23-023420 | Feb 3, 2023 | — |
| SC 13G | — | 0001214659-22-006811 | May 13, 2022 | — |
| SC 13G | — | 0001193805-22-000769 | May 11, 2022 | — |
| SC 13G | SC 13G | 0001193125-21-045007 | Feb 16, 2021 | — |
| SC 13G | SC 13G | 0001193125-21-044761 | Feb 16, 2021 | — |
| SC 13G | SC 13G | 0001193125-21-041924 | Feb 12, 2021 | — |
| SC 13G | SC 13G | 0001193125-21-041919 | Feb 12, 2021 | — |
| SC 13G | — | 0000929638-20-001063 | Oct 30, 2020 | — |
| SC 13G | SCHEDULE 13G | 0001213900-20-033708 | Oct 28, 2020 | — |
| SC 13G | — | 0001493152-20-019928 | Oct 26, 2020 | — |
| SC 13G | SCHEDULE 13G | 0001193125-20-275234 | Oct 23, 2020 | — |